Compare MMLP & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMLP | DRIO |
|---|---|---|
| Founded | 2002 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.3M | 82.2M |
| IPO Year | 2002 | N/A |
| Metric | MMLP | DRIO |
|---|---|---|
| Price | $2.62 | $10.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 26.5K | 26.4K |
| Earning Date | 02-11-2026 | 11-13-2025 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $713,263,000.00 | $24,732,000.00 |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | N/A | $20.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $2.21 | $5.94 |
| 52 Week High | $4.02 | $31.00 |
| Indicator | MMLP | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 36.66 |
| Support Level | $2.21 | $11.93 |
| Resistance Level | $2.61 | $12.88 |
| Average True Range (ATR) | 0.16 | 0.75 |
| MACD | 0.02 | -0.21 |
| Stochastic Oscillator | 61.62 | 4.83 |
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.